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, the prevalence of diabetes among population aged > 25 year is 4.2%, while Shera et al 2, 3 have estimated a prevalence of 9.1 to 13.7%. These figures translate into 4-8 million diabetics in the country. For every patient who is known to have diabetes another has the disease unaware. 4 It is a significant cause of multi-system disease including cardiovascular disease, renal failure and blindness. Even though the diagnosis of diabetes mellitus may be anticipated by its classical signs and symptoms; weight loss, fatigue, a history of polydipsia (excessive thirst) and polyuria (excessive urinating), the diagnosis should not rely only on the presence of glycosuria (sugar in the urine). The diagnosis must be confirmed by demonstrating the presence of fasting hyperglycemia (raised blood sugar) and following an oral glucose tolerance test. 5 Twenty years after the onset of diabetes nearly all patients with type I diabetes (insulin-dependent) and more than 60% of those with type II diabetes (non insulin-dependent) will have retinopathy. 6 Diabetic retinopathy is the leading cause of blindness amongst people of working age in industrialized countries. 7 It is estimated that there are 20 million diabetics in the Middle East (WHO Eastern Mediterranean Region), of which 800,000 will require treatment for retinopathy, and 116,000 new patients will present for treatment each year. 8 In Singapore, 8.6% of the population between 15 and 69 years is diabetic, that is, 165,000 diabetics and at least 16,500 of these will have retinopathy 9 . Pilot studies performed by Khan However, it does seem likely that blinding diabetic eye disease is now the fourth major cause of blindness worldwide after cataract, glaucoma and trachoma. Diabetic retinopathy can cause several types of vitreoretinal pathology, each a consequence of microvascular damage to the retina. The 3 main categories are nonproliferative diabetic retinopathy (NPDR), proliferative diabetic retinopathy (PDR), and diabetic macular edema (DME). DME can coexist with any stage or severity of NPDR or PDR. Although, the 'ideal screening method does not exist' and many in developing countries will not have available sophisticated equipment for screening, all primary care workers should be aware that diabetes is a public health problem in their region and make sure that diabetic patients have regular, dilated view ophthalmoscopy.
The recommendations for screening of diabetic retinopathy by the American Academy of Ophthalmology and the American Diabetic Association are that; a newly diagnosed Type I diabetic should get their initial retina examination within 5 years after diagnosis. Follow-up examinations should be annual thereafter unless, there is moderate to severe diabetic retinopathy in which case examinations have to be more frequent. Newly diagnosed Type II diabetics should receive their initial examination immediately. Follow-up examinations may be conducted similarly to Type I diabetics.
Early treatment using laser photocoagulation has been shown to reduce blindness due to diabetic retinopathy by at least 60% and the figure will improve further as patients at risk are identified early: the earlier the better. 6 Late diagnosis of diabetic retinopathy may require complex vitreo-retinal surgical procedures for treatment and often leave the patient with irreversible loss of vision.
In conclusion, recognition of the increasing problem of diabetes mellitus and its danger to sight, training in ophthalmoscopy (and other diagnostic methods, if possible), early identification of the stages of retinopathy in patients at risk and referral for expert opinion and treatment, will prevent blindness for many individuals in vulnerable communities around the world. Blindness from diabetic retinopathy is almost inevitable if left unmanaged. Screening protocols need to be established at primary, secondary and tertiary referral centers at the provincial and national levels. Early identification of
